|
Cherian, M George; Kang, Y James (2006) Metallothionein and liver cell regeneration. Exp Biol Med (Maywood) 231:138-44
|
|
Kang, Y James; Sun, Xiuhua; Chen, Yan et al. (2002) Inhibition of doxorubicin chronic toxicity in catalase-overexpressing transgenic mouse hearts. Chem Res Toxicol 15:1-6
|
|
Sun, X; Zhou, Z; Kang, Y J (2001) Attenuation of doxorubicin chronic toxicity in metallothionein-overexpressing transgenic mouse heart. Cancer Res 61:3382-7
|
|
Wang, G W; Klein, J B; Kang, Y J (2001) Metallothionein inhibits doxorubicin-induced mitochondrial cytochrome c release and caspase-3 activation in cardiomyocytes. J Pharmacol Exp Ther 298:461-8
|
|
Lambert, J C; Wang, G W; Kang, Y J (2001) Zinc inhibition of caspase-3 activation does not protect HeLa cells from apoptotic cell death. Toxicol Appl Pharmacol 175:89-93
|
|
Wang, G W; Zhou, Z; Klein, J B et al. (2001) Inhibition of hypoxia/reoxygenation-induced apoptosis in metallothionein-overexpressing cardiomyocytes. Am J Physiol Heart Circ Physiol 280:H2292-9
|
|
Kang, Y J (2001) Molecular and cellular mechanisms of cardiotoxicity. Environ Health Perspect 109 Suppl 1:27-34
|
|
Kang, Y J; Zhou, Z X; Wu, H et al. (2000) Metallothionein inhibits myocardial apoptosis in copper-deficient mice: role of atrial natriuretic peptide. Lab Invest 80:745-57
|
|
Cai, L; Klein, J B; Kang, Y J (2000) Metallothionein inhibits peroxynitrite-induced DNA and lipoprotein damage. J Biol Chem 275:38957-60
|
|
Zhou, Z; Kang, Y J (2000) Cellular and subcellular localization of catalase in the heart of transgenic mice. J Histochem Cytochem 48:585-94
|
Showing the most recent 10 out of 22 publications
